Dole G - Search Results

1

Functional Outcome of Intertrochanteric Fractures of the Femur Treated With Standard Surgical Modalities.

Argekar H, Dole G, Shinde M, Patel M, Patil YH, Sharma A, Sarwey K, Datta R, Modi A, Sathe S. Argekar H, et al. Among authors: dole g. Cureus. 2024 Oct 5;16(10):e70909. doi: 10.7759/cureus.70909. eCollection 2024 Oct. Cureus. 2024. PMID: 39502978 Free PMC article.

2

Neurotrophin NT3 promotes ovarian primordial to primary follicle transition.

Nilsson E, Dole G, Skinner MK. Nilsson E, et al. Among authors: dole g. Reproduction. 2009 Oct;138(4):697-707. doi: 10.1530/REP-09-0179. Epub 2009 Jul 7. Reproduction. 2009. PMID: 19584175 Free PMC article.

3

Glial-derived neurotrophic factor promotes ovarian primordial follicle development and cell-cell interactions during folliculogenesis.

Dole G, Nilsson EE, Skinner MK. Dole G, et al. Reproduction. 2008 May;135(5):671-82. doi: 10.1530/REP-07-0405. Epub 2008 Feb 27. Reproduction. 2008. PMID: 18304989 Free PMC article.

4

Marketing feedback.

Dole G. Dole G. Mark Health Serv. 2006 Spring;26(1):43. Mark Health Serv. 2006. PMID: 16579366 No abstract available.

5

An integrated mobile foot and retinal screening programme for people with Type 2 diabetes managed in primary care.

Sampson MJ, Shepstone L, Greenwood RH, Harvey I, Humphries J, Heyburn PJ, Temple RC, Dole G. Sampson MJ, et al. Among authors: dole g. Diabet Med. 2002 Jan;19(1):74-6. doi: 10.1046/j.1464-5491.2002.00639.x. Diabet Med. 2002. PMID: 11869307

6

Characteristics of underserved women who did and those who did not use a free/low-cost voucher as part of a mammography screening program.

Dole GF, Carney PA. Dole GF, et al. J Cancer Educ. 1998 Summer;13(2):102-7. doi: 10.1080/08858199809528525. J Cancer Educ. 1998. PMID: 9659629

7

Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.

Grochow LB, Noe DA, Dole GB, Rowinsky EK, Ettinger DS, Graham ML, McGuire WP, Donehower RC. Grochow LB, et al. Among authors: dole gb. J Natl Cancer Inst. 1989 Jan 18;81(2):124-30. doi: 10.1093/jnci/81.2.124. J Natl Cancer Inst. 1989. PMID: 2909752

8

In vivo cell growth and pharmacologic determinants of clinical response in acute myelogenous leukemia.

Karp JE, Donehower RC, Enterline JP, Dole GB, Fox MG, Burke PJ. Karp JE, et al. Among authors: dole gb. Blood. 1989 Jan;73(1):24-30. Blood. 1989. PMID: 2910362 Free article.

9

Correlation of drug-perturbed marrow cell growth kinetics and intracellular 1-B-D-arabinofuranosylcytosine metabolism with clinical response in adult acute myelogenous leukemia.

Karp JE, Donehower RC, Dole GB, Burke PJ. Karp JE, et al. Among authors: dole gb. Blood. 1987 Apr;69(4):1134-40. Blood. 1987. PMID: 3470054 Free article.

10

Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.

Karp JE, Donehower RC, Dole GB, Burke PJ. Karp JE, et al. Among authors: dole gb. Cancer Res. 1984 Nov;44(11):5046-50. Cancer Res. 1984. PMID: 6488163

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters